Cargando…

Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure

BACKGROUND: Isoproterenol-induced cardiac hypertrophy in mice has been used in a number of studies to model human cardiac disease. In this study, we compared the transcriptional response of the heart in this model to other animal models of heart failure, as well as to the transcriptional response of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galindo, Cristi L, Skinner, Michael A, Errami, Mounir, Olson, L Danielle, Watson, David A, Li, Jing, McCormick, John F, McIver, Lauren J, Kumar, Neil M, Pham, Thinh Q, Garner, Harold R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799380/ https://www.ncbi.nlm.nih.gov/pubmed/20003209 http://dx.doi.org/10.1186/1472-6793-9-23

Ejemplares similares

Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy
por: Errami, Mounir, et al.
Publicado: (2010)

Circular RNA expression in isoproterenol hydrochloride-induced cardiac hypertrophy
por: Yang, Ming-Hui, et al.
Publicado: (2020)

Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats
por: Chakraborty, Songjukta, et al.
Publicado: (2015)

Cardiac macrophages regulate isoproterenol-induced Takotsubo-like cardiomyopathy
por: Liao, Xudong, et al.
Publicado: (2022)

A species independent universal bio-detection microarray for pathogen forensics and phylogenetic classification of unknown microorganisms
por: Shallom, Shamira J, et al.
Publicado: (2011)

Protective Role for LPA(3) in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol
por: Cai, Lin, et al.
Publicado: (2017)

The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy
por: Gan, Mailin, et al.
Publicado: (2020)

Syringic acid mitigates isoproterenol‐induced cardiac hypertrophy and fibrosis by downregulating Ereg
por: Han, Xiongyi, et al.
Publicado: (2022)

Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway
por: Al-rasheed, Nouf M, et al.
Publicado: (2015)

Hydrogen (H(2)) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways
por: Zhang, Yaxing, et al.
Publicado: (2016)

Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy
por: Liu, Qian, et al.
Publicado: (2015)

Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis
por: Althurwi, Hassan N., et al.
Publicado: (2020)

Identification of serum predictors of n-acetyl-l-cysteine and isoproterenol induced remodelling in cardiac hypertrophy
por: KUBERAPANDIAN, Dharaniyambigai, et al.
Publicado: (2021)

A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats
por: Chowdhury, Debabrata, et al.
Publicado: (2013)

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun
por: Ming, Su, et al.
Publicado: (2018)

Allylmethylsulfide, a Sulfur Compound Derived from Garlic, Attenuates Isoproterenol-Induced Cardiac Hypertrophy in Rats
por: Mohammed, Soheb Anwar, et al.
Publicado: (2020)

Dendrobium candidum aqueous extract attenuates isoproterenol-induced cardiac hypertrophy through the ERK signalling pathway
por: Cao, Yuan-Yuan, et al.
Publicado: (2020)

Difluoromethylornithine attenuates isoproterenol-induced cardiac hypertrophy by regulating apoptosis, autophagy and the mitochondria-associated membranes pathway
por: Zhao, Yu, et al.
Publicado: (2021)

Effectual Endeavors of Silk Protein Sericin against Isoproterenol Induced Cardiac Toxicity and Hypertrophy in Wistar Rats
por: Ahsan, Farogh, et al.
Publicado: (2022)

Amlexanox and Forskolin Prevents Isoproterenol-Induced Cardiomyopathy by Subduing Cardiomyocyte Hypertrophy and Maladaptive Inflammatory Responses
por: Adzika, Gabriel Komla, et al.
Publicado: (2021)

Citrus medica “Otroj”: Attenuates Oxidative Stress and Cardiac Dysrhythmia in Isoproterenol-Induced Cardiomyopathy in Rats
por: Al-Yahya, Mohammed A., et al.
Publicado: (2013)

Rapamycin Attenuated Cardiac Hypertrophy Induced by Isoproterenol and Maintained Energy Homeostasis via Inhibiting NF-κB Activation
por: Chen, Xi, et al.
Publicado: (2014)

Toll-Like Receptor 4 Inhibition Improves Oxidative Stress and Mitochondrial Health in Isoproterenol-Induced Cardiac Hypertrophy in Rats
por: Katare, Parmeshwar B., et al.
Publicado: (2017)

Targeting the Nrf2/ARE Signalling Pathway to Mitigate Isoproterenol-Induced Cardiac Hypertrophy: Plausible Role of Hesperetin in Redox Homeostasis
por: Velusamy, Prema, et al.
Publicado: (2020)

Transcriptomic Validation of the Protective Effects of Aqueous Bark Extract of Terminalia arjuna (Roxb.) on Isoproterenol-Induced Cardiac Hypertrophy in Rats
por: Kumar, Gaurav, et al.
Publicado: (2019)

Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway
por: Zhao, Tingwei, et al.
Publicado: (2021)

Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes
por: Bavarva, Jasmin H., et al.
Publicado: (2014)

Modulatory effect of semelil (ANGIPARS™) on isoproterenol induced cardiac injury
por: Joukar, Siyavash, et al.
Publicado: (2013)

Phosphocreatine Attenuates Isoproterenol-Induced Cardiac Fibrosis and Cardiomyocyte Apoptosis
por: Dai, Hui, et al.
Publicado: (2019)

Musa balbisiana Fruit Rich in Polyphenols Attenuates Isoproterenol-Induced Cardiac Hypertrophy in Rats via Inhibition of Inflammation and Oxidative Stress
por: Kumari, Sima, et al.
Publicado: (2020)

STVNa Attenuates Isoproterenol-Induced Cardiac Hypertrophy Response through the HDAC4 and Prdx2/ROS/Trx1 Pathways
por: Liu, Fei, et al.
Publicado: (2020)

Protocatechuic acid attenuates isoproterenol-induced cardiac hypertrophy via downregulation of ROCK1–Sp1–PKCγ axis
por: Bai, Liyan, et al.
Publicado: (2021)

Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy–Associated Cardiomyopathy
por: Parvatiyar, Michelle S., et al.
Publicado: (2015)

Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity
por: Ryu, Yuhee, et al.
Publicado: (2016)

Pyrroloquinoline quinone attenuates isoproterenol hydrochloride-induced cardiac hypertrophy in AC16 cells by inhibiting the NF-κB signaling pathway
por: Wen, Junru, et al.
Publicado: (2020)

Effect of LCZ696, a dual angiotensin receptor neprilysin inhibitor, on isoproterenol-induced cardiac hypertrophy, fibrosis, and hemodynamic change in rats
por: Miyoshi, Toru, et al.
Publicado: (2019)

CD47 Deficiency Attenuates Isoproterenol-Induced Cardiac Remodeling in Mice
por: Zuo, Zhi, et al.
Publicado: (2019)

Diallyl disulfide ameliorates isoproterenol induced cardiac hypertrophy activating mitochondrial biogenesis via eNOS-Nrf2-Tfam pathway in rats
por: Khatua, Tarak Nath, et al.
Publicado: (2015)

iTRAQ-based quantitative proteomics analysis of the potential application of secretoneurin gene therapy for cardiac hypertrophy induced by DL-isoproterenol hydrochloride in mice
por: Chen, Huali, et al.
Publicado: (2020)

Signaling via the Interleukin-10 Receptor Attenuates Cardiac Hypertrophy in Mice During Pressure Overload, but not Isoproterenol Infusion
por: Stafford, Nicholas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_15hrl65gnc5bsgbf502be1jjom